Showing results (111-120 of 117) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Bone Marrow Transplantation|September 22, 2019
Outcome in patients with diffuse large B-cell lymphoma who relapse after autologous stem cell transplantation and receive active therapy. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)E González-Barca, A Boumendil, D Blaise, et al.Bone Marrow Transplantation|May 23, 2017
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working PartyL Bento, A Boumendil, H Finel, et al.Bone Marrow Transplantation|December 13, 2016
Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow TransplantationM van Gelder, L C de Wreede, M Bornhäuser, et al.Bone Marrow Transplantation|January 22, 2019
EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)W Wiktor-Jedrzejczak, J Drozd-Sokolowska, D J Eikema, et al.Bone Marrow Transplantation|June 21, 2026
Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMTA Kanellopoulos, M Labopin, A Spyridonidis, et al.Bone Marrow Transplantation|December 8, 2015
Prognostic impact of progression to induction chemotherapy and prior paclitaxel therapy in patients with germ cell tumors receiving salvage high-dose chemotherapy in the last 10 years: a study of the European Society for Blood and Marrow Transplantation Solid Tumors Working PartyA Necchi, R Miceli, M Bregni, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2011
No improvement of survival with reduced- versus high-intensity conditioning for allogeneic stem cell transplants in Ewing tumor patientsU Thiel, A Wawer, P Wolf, et al.Pageof 12